statements

Celestial Biolabs Ltd

NSE: CELESTIAL

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1.75+0.0 (+0.00%)

16 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Celestial Biolabs Ltd income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	C 2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2024 Mar 31
	2010 Mar 31	C 2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2024 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR	12M PRESS	12M AR
Total Revenue	21.53	25.22	20.59	21.16	23.50	27.45	32.86	38.66	42.81	48.97	0.17
Cost of Operating Revenue	11.85	15.22	11.30	13.65	14.17	13.01	24.55	31.04	36.38	38.14	0.13
Gross Profit	9.68	10.00	9.29	7.51	9.34	14.44	8.31	7.62	6.44	10.83	0.03
Gross Margin	44.9	39.7	45.1	35.5	39.7	52.6	25.3	19.7	15.0	22.1	20.3
Total Operating Expenses	17.93	22.34	20.09	20.20	20.73	22.08	30.01	34.97	38.68	46.68	0.74
Operating Profit	3.60	2.89	0.50	0.96	2.77	5.38	2.85	3.69	4.13	2.30	-0.57
Operating Margin	16.7	11.4	2.4	4.5	11.8	19.6	8.7	9.6	9.7	4.7	-339.7
Financing Income/(Expense) - Net	0.06	-0.10	-0.64	-0.69	-2.22	-4.15	-1.29	-0.02	-0.03	-1.25	-0.01
Profit before Taxes	2.66	2.79	0.28	0.31	0.55	1.23	1.85	3.67	4.11	1.40	-0.58
Income Taxes	0.32	0.37	-0.63	-0.40	-0.29	-0.07	-0.23	0.34	0.78	1.43	-
Profit after Tax	2.34	2.42	0.92	0.71	0.84	1.30	2.08	3.33	3.33	-0.03	-0.58
PAT Margin	10.9	9.6	4.4	3.3	3.6	4.7	6.3	8.6	7.8	-0.1	-344.6
EPS - Basic - ex Extraordinary Items	1.98	1.66	0.63	0.49	0.49	0.70	1.02	1.48	1.47	-0.01	-0.26
EPS - Diluted - ex Extraordinary Items	1.89	1.66	0.63	0.49	0.49	0.70	0.92	1.48	1.47	-0.01	-0.26
EBIT	3.60	2.89	0.50	0.96	2.77	5.38	2.85	3.69	4.13	2.30	-0.57
EBITDA	4.10	6.04	4.23	5.69	7.75	12.43	8.56	7.00	11.83	11.74	-0.54
EBITDA Margin	19.0	23.9	20.5	26.9	33.0	45.3	26.0	18.1	27.6	24.0	-322.9

Balance Sheet

Abridged

Understanding Balance Sheet

Celestial Biolabs Ltd balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	C 2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2024 Mar 31
	2010 Mar 31	C 2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2024 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS	AR
Total Current Assets	8.46	23.63	30.83	33.40	42.92	46.14	48.69	17.84	31.00	22.58	4.34
Long-Term Investments	4.15	-	-	-	-	-	0.30	0.30	0.30	-	-
Property Plant & Equipment - Net	55.38	67.47	61.49	61.92	61.50	52.97	43.68	42.84	42.40	41.72	12.90
Total Non-Current Assets	68.65	67.47	61.49	61.92	61.50	52.97	56.31	90.71	82.96	96.75	12.90
Total Assets	77.11	91.10	92.32	95.32	104.42	99.11	104.99	108.55	113.95	119.33	17.24
Total Current Liabilities	0.73	1.16	0.45	0.62	0.56	1.44	1.69	1.35	2.26	7.84	5.49
Long Term Debt	5.71	10.93	12.65	15.22	18.44	11.17	8.25	8.25	9.42	7.82	8.98
Total Non-Current Liabilities	7.29	12.31	13.32	15.44	18.26	11.05	7.79	8.35	9.39	9.22	8.98
Total Liabilities	8.02	13.47	13.77	16.06	18.81	12.50	9.48	9.70	11.65	17.06	14.47
Total Shareholders' Equity	69.08	77.63	78.55	79.26	85.60	86.62	95.51	98.84	102.30	102.27	2.77
Minority Interest	-	-	-	-	-	-	-	-	-	-	0.00
Total Equity	69.08	77.63	78.55	79.26	85.60	86.62	95.51	98.84	102.30	102.27	2.77
Total Liabilities & Equity	77.11	91.10	92.32	95.32	104.42	99.11	104.99	108.55	113.95	119.33	17.24

Cash Flow

Abridged

Understanding Cash Flow Statement

Celestial Biolabs Ltd cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	C 2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2024 Mar 31
	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	C 2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2024 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	3.23	6.14	4.72	5.50	5.93	8.59	8.14	7.34	11.93	-0.55
Working Capital - Increase/(Decrease)	-0.25	-5.26	-2.17	-1.71	-4.88	-6.95	-1.30	6.05	-8.62	0.20
Net CF from Operating Activities	2.98	0.88	2.55	3.79	1.05	1.64	6.84	13.39	3.31	-0.36
Capital Expenditures - Net	9.69	15.24	-2.25	5.16	4.56	3.60	9.34	-	-	0.01
Net CF from Investing Activities	-6.89	-16.59	-4.17	-6.36	-8.19	-3.60	-11.61	-13.89	-4.88	-0.01
Debt - LT & ST - Issuance/(Retirement) - Total	-0.04	5.43	1.71	2.57	2.01	1.06	2.92	-	1.17	0.38
Net Cash Flow from Financing Activities	8.02	11.56	1.71	2.57	7.51	2.26	4.85	-	1.17	0.38
Free Cash Flow to Equity	-6.75	-8.93	6.51	1.21	-1.50	-0.91	0.42	13.39	4.48	0.01
Free Operating CF net dividend	-6.71	-14.36	-10.84	-1.37	-3.51	-1.96	-2.50	13.39	3.31	-0.36
Free Operating CF	-6.71	-14.36	-10.84	-1.37	-3.51	-1.96	-2.50	13.39	3.31	-0.36

Business Segment Analysis

Celestial Biolabs Ltd business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Celestial Biolabs Ltd

Regional Segment Analysis

Celestial Biolabs Ltd geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Celestial Biolabs Ltd

Historical Segment Analysis

Track how Celestial Biolabs Ltd segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Celestial Biolabs Ltd

Frequently Asked Questions

What is the revenue of Celestial Biolabs Ltd?

The latest trailing twelve month revenue of Celestial Biolabs Ltd is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Celestial Biolabs Ltd?

The latest trailing twelve month net profit (PAT) of Celestial Biolabs Ltd is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Celestial Biolabs Ltd?

The operating margin of Celestial Biolabs Ltd is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Celestial Biolabs Ltd?

The trailing twelve month Earnings Per Share (EPS) of Celestial Biolabs Ltd is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Celestial Biolabs Ltd?

The debt-to-equity ratio of Celestial Biolabs Ltd stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Celestial Biolabs Ltd?

The book value per share of Celestial Biolabs Ltd is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Celestial Biolabs Ltd?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Celestial Biolabs Ltd report consolidated or standalone financials?

Celestial Biolabs Ltd reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.